167 related articles for article (PubMed ID: 18268157)
1. Cardiovascular research funding in Europe: The Netherlands. Interview by Jennifer Taylor.
Doevendans P
Circulation; 2008 Feb; 117(6):f31-3. PubMed ID: 18268157
[No Abstract] [Full Text] [Related]
2. Centres of excellence: a Spanish cardiovascular research initiative. Interview by Jennifer Taylor.
Fuster V
Circulation; 2007 May; 115(21):f104-6. PubMed ID: 17536248
[No Abstract] [Full Text] [Related]
3. Breaking through. Upbeat reports on medical research highlight value of federal, private funding.
May D
Mod Healthc; 2011 Aug; 41(35):25. PubMed ID: 21932707
[No Abstract] [Full Text] [Related]
4. Public-private partnerships in drug development for underdeveloped countries: an interview with Craig Wheeler, President of Chiron's Biopharmaceutical Division. Interview by Thomasine Kushner.
Wheeler C
Camb Q Healthc Ethics; 2003; 12(4):429-33. PubMed ID: 14619375
[No Abstract] [Full Text] [Related]
5. Declines in NIH R01 research grant funding.
Mandel HG; Vesell ES
Science; 2008 Oct; 322(5899):189. PubMed ID: 18845728
[No Abstract] [Full Text] [Related]
6. The promise of South African biotech.
Akermann B; Kermani F
Drug Discov Today; 2006 Nov; 11(21-22):962-5. PubMed ID: 17055404
[No Abstract] [Full Text] [Related]
7. A new era of hope for the world's most neglected diseases.
The
PLoS Med; 2005 Sep; 2(9):e323. PubMed ID: 16138790
[TBL] [Abstract][Full Text] [Related]
8. Translational research in Berlin hits a roadblock.
Abbott A
Nature; 2009 Jan; 457(7228):362-3. PubMed ID: 19158751
[No Abstract] [Full Text] [Related]
9. Addressing the decline in NIH pain research funding.
Max MB
J Pain; 2008 Dec; 9(12):1074-6. PubMed ID: 19038769
[No Abstract] [Full Text] [Related]
10. [Views on the financing of biomedical scientific research; the report 'Erop of eronder' (Sink or swim) from the KNAW (Royal Netherlands Academy of Arts and Sciences)].
Stukart MJ; van der Meer JW; Löwenberg B
Ned Tijdschr Geneeskd; 2006 Oct; 150(42):2297-300. PubMed ID: 17089545
[TBL] [Abstract][Full Text] [Related]
11. Data sharing: making headway in a competitive research milieu.
Samson K
Ann Neurol; 2008 Jul; 64(1):A13-6. PubMed ID: 18668610
[No Abstract] [Full Text] [Related]
12. Re: Corporations flock to selling for the (breast cancer) cure.
Braun S
J Natl Cancer Inst; 2005 Feb; 97(4):320. PubMed ID: 15713970
[No Abstract] [Full Text] [Related]
13. Global health. Public-private partnerships proliferate.
Cohen J
Science; 2006 Jan; 311(5758):167. PubMed ID: 16410497
[No Abstract] [Full Text] [Related]
14. Cardiovascular research funding in Europe: the United Kingdom. Interview by Jennifer Taylor.
Noble D
Circulation; 2008 Mar; 117(9):f49-51. PubMed ID: 18316495
[No Abstract] [Full Text] [Related]
15. Corporations flock to selling for the (breast cancer) cure.
Twombly R
J Natl Cancer Inst; 2004 Dec; 96(23):1736-7. PubMed ID: 15572752
[No Abstract] [Full Text] [Related]
16. Public health. Public-private partnerships and scientific imperialism.
Tucker TJ; Makgoba MW
Science; 2008 May; 320(5879):1016-7. PubMed ID: 18497279
[No Abstract] [Full Text] [Related]
17. Taking risks with translational research.
Mills IG; Sykes RB
Sci Transl Med; 2010 Mar; 2(24):24cm10. PubMed ID: 20375005
[TBL] [Abstract][Full Text] [Related]
18. Private funding for molecular evolution.
Lehman N
J Mol Evol; 2014 May; 78(5):243-4. PubMed ID: 24817570
[No Abstract] [Full Text] [Related]
19. [From political to institutional action: research priorities in the Ministry of Health].
Rev Saude Publica; 2006 Jun; 40(3):548-52. PubMed ID: 16810383
[No Abstract] [Full Text] [Related]
20. Worldwide under-funding of stroke research.
Pendlebury ST
Int J Stroke; 2007 May; 2(2):80-4. PubMed ID: 18705958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
